Market Closed -
Sao Paulo
16:07:00 2024-07-17 EDT
|
5-day change
|
1st Jan Change
|
2.4
BRL
|
-2.83%
|
|
-8.75%
|
-82.80%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,399
|
4,570
|
4,465
|
764.4
|
-
|
-
|
Enterprise Value (EV)
1 |
5,472
|
5,887
|
7,410
|
3,684
|
3,622
|
3,774
|
P/E ratio
|
12.5
x
|
17.6
x
|
11.6
x
|
-327
x
|
5.32
x
|
3.41
x
|
Yield
|
2.14%
|
1.72%
|
-
|
1.15%
|
8.73%
|
9.11%
|
Capitalization / Revenue
|
0.87
x
|
0.52
x
|
0.4
x
|
0.06
x
|
0.06
x
|
0.05
x
|
EV / Revenue
|
0.88
x
|
0.67
x
|
0.67
x
|
0.31
x
|
0.28
x
|
0.27
x
|
EV / EBITDA
|
11.6
x
|
8.05
x
|
7.99
x
|
5.48
x
|
3.82
x
|
3.65
x
|
EV / FCF
|
40.1
x
|
-5.56
x
|
-5.1
x
|
4.36
x
|
10.3
x
|
11.4
x
|
FCF Yield
|
2.5%
|
-18%
|
-19.6%
|
22.9%
|
9.73%
|
8.8%
|
Price to Book
|
2.51
x
|
2
x
|
1.36
x
|
0.23
x
|
0.23
x
|
0.23
x
|
Nbr of stocks (in thousands)
|
286,123
|
283,350
|
320,047
|
318,494
|
-
|
-
|
Reference price
2 |
18.87
|
16.13
|
13.95
|
2.400
|
2.400
|
2.400
|
Announcement Date
|
22-03-10
|
23-03-09
|
24-03-25
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
6,219
|
8,747
|
11,084
|
11,856
|
12,955
|
14,127
|
EBITDA
1 |
-
|
471.4
|
731.4
|
927.5
|
672
|
948.3
|
1,034
|
EBIT
1 |
-
|
373.2
|
555
|
666.9
|
429.3
|
666.5
|
694.9
|
Operating Margin
|
-
|
6%
|
6.35%
|
6.02%
|
3.62%
|
5.14%
|
4.92%
|
Earnings before Tax (EBT)
1 |
-
|
408.9
|
208.1
|
138.5
|
-64.75
|
250.1
|
268.5
|
Net income
1 |
121.8
|
395.2
|
259.7
|
359.9
|
5.898
|
216.7
|
226.3
|
Net margin
|
-
|
6.35%
|
2.97%
|
3.25%
|
0.05%
|
1.67%
|
1.6%
|
EPS
2 |
0.5436
|
1.510
|
0.9154
|
1.200
|
-0.007340
|
0.4510
|
0.7047
|
Free Cash Flow
1 |
-
|
136.6
|
-1,059
|
-1,452
|
844.5
|
352.3
|
332
|
FCF margin
|
-
|
2.2%
|
-12.11%
|
-13.1%
|
7.12%
|
2.72%
|
2.35%
|
FCF Conversion (EBITDA)
|
-
|
28.98%
|
-
|
-
|
125.68%
|
37.15%
|
32.12%
|
FCF Conversion (Net income)
|
-
|
34.57%
|
-
|
-
|
14,318.24%
|
162.59%
|
146.69%
|
Dividend per Share
2 |
-
|
0.4046
|
0.2769
|
-
|
0.0275
|
0.2094
|
0.2187
|
Announcement Date
|
21-03-18
|
22-03-10
|
23-03-09
|
24-03-25
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
1,621
|
1,900
|
1,946
|
2,274
|
2,627
|
2,800
|
2,534
|
2,845
|
2,905
|
2,958
|
2,813
|
3,056
|
3,145
|
3,271
|
-
|
EBITDA
1 |
128.9
|
167.3
|
176.1
|
188.7
|
199.3
|
223.2
|
251.1
|
250.8
|
202.5
|
151.6
|
173.2
|
200.4
|
206.2
|
-
|
-
|
EBIT
1 |
104.2
|
-
|
138.8
|
144.3
|
145.2
|
162.1
|
185.3
|
167.6
|
135.6
|
77.93
|
78.65
|
125.6
|
129.1
|
-
|
-
|
Operating Margin
|
6.43%
|
-
|
7.13%
|
6.34%
|
5.53%
|
5.79%
|
7.31%
|
5.89%
|
4.67%
|
2.63%
|
2.8%
|
4.11%
|
4.1%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
30.34
|
-43.01
|
-34.22
|
6.47
|
8.238
|
-
|
-
|
Net income
|
81.62
|
97
|
-
|
-
|
63.18
|
36.89
|
55.47
|
6.315
|
261.2
|
3.043
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
5.03%
|
5.11%
|
-
|
-
|
2.41%
|
1.32%
|
2.19%
|
0.22%
|
8.99%
|
0.1%
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.2800
|
-
|
0.1612
|
0.1901
|
0.2235
|
0.1302
|
0.1958
|
0.0206
|
0.8530
|
0.009530
|
-0.1225
|
-0.0491
|
0.0808
|
0.0600
|
0.0700
|
Dividend per Share
2 |
0.4046
|
-
|
-
|
-
|
0.2769
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22-03-10
|
22-05-09
|
22-08-09
|
22-11-10
|
23-03-09
|
23-05-11
|
23-08-14
|
23-11-13
|
24-03-25
|
24-05-09
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
72.5
|
1,316
|
2,946
|
2,920
|
2,858
|
3,009
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.1538
x
|
1.8
x
|
3.176
x
|
4.345
x
|
3.014
x
|
2.911
x
|
Free Cash Flow
1 |
-
|
137
|
-1,059
|
-1,452
|
845
|
352
|
332
|
ROE (net income / shareholders' equity)
|
-
|
23.6%
|
11.7%
|
12.9%
|
0.86%
|
4.39%
|
6.48%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
3.16%
|
3.65%
|
0.01%
|
0.84%
|
1.5%
|
Assets
1 |
-
|
-
|
8,229
|
9,873
|
53,619
|
25,676
|
15,119
|
Book Value Per Share
2 |
-
|
7.520
|
8.050
|
10.30
|
10.30
|
10.50
|
10.50
|
Cash Flow per Share
|
-
|
0.8200
|
-
|
-2.980
|
-
|
-
|
-
|
Capex
1 |
-
|
78
|
1,592
|
556
|
165
|
239
|
268
|
Capex / Sales
|
-
|
1.25%
|
18.2%
|
5.02%
|
1.39%
|
1.84%
|
1.89%
|
Announcement Date
|
21-03-18
|
22-03-10
|
23-03-09
|
24-03-25
|
-
|
-
|
-
|
Average target price
7.725
BRL Spread / Average Target +221.88% Consensus |
1st Jan change
|
Capi.
|
---|
| -82.80% | 140M | | +25.72% | 75.5B | | -4.79% | 23.38B | | +17.81% | 8.96B | | -31.67% | 6.83B | | +22.16% | 5.59B | | +4.19% | 4.26B | | -3.94% | 4B | | +13.98% | 3.49B | | +10.59% | 3.29B |
Pharmaceuticals Wholesale
|